Interaction of Bile with Erythromycin Lactobionate in vitro*
- 1 February 1975
- journal article
- Published by Wiley in Australian and New Zealand Journal of Medicine
- Vol. 5 (1), 25-31
- https://doi.org/10.1111/j.1445-5994.1975.tb03250.x
Abstract
An interaction of bile with erythromycin lactobionate in vitro has been demonstrated. The major bile components involved in this interaction have been shown to be the bile salts. The nature of the bile salt-erythromycin interaction has been investigated. The way in which an interaction between bile salts and erythromycin in vivo might lead to the hepatic dysfunction and cholestasis associated with some instances of erythromycin therapy is discussed.Keywords
This publication has 11 references indexed in Scilit:
- Phenothiazines and Jaundice§Australian and New Zealand Journal of Medicine, 1972
- Perfusion of the Isolated Rat Liver with Erythromycin Estolate and Other DerivativesExperimental Biology and Medicine, 1972
- Ultrastructural studies of the hepatic changes brought about by clindamycin and erythromycin in animalsToxicology and Applied Pharmacology, 1971
- GALLSTONE FORMATIONThe Lancet, 1971
- Pathophysiology of cholestasisHuman Pathology, 1970
- The structure and stereochemistry of erythromycin A.Tetrahedron Letters, 1965
- The surface activity of tranquilizersBiochemical Pharmacology, 1963
- EFFECTS OF SOME ANTIMICROBIAL AGENTS ON THE LIVER*Annals of the New York Academy of Sciences, 1963
- Cholestatic Hepatitis Caused by Esters of Erythromycin and OleandomycinPublished by American Medical Association (AMA) ,1962
- HEPATIC DYSFUNCTION ASSOCIATED WITH TRIACETYLOLEANDOMYCIN AND PROPIONYL ERYTHROMYCIN ESTER LAURYL SULFATEThe American Journal of the Medical Sciences, 1962